Doctor profile · Federal record
Dr. Mark Mastrodicasa, MD
Critical Care Medicine (Internal Medicine) Physician (CMS: Pulmonary Disease) · Internal Medicine Physician · Pulmonary Disease Physician · Indianapolis, IN
- NPI 1144548967
- Accepts Medicare
- 17 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
8333 Naab RD Ste 250
Indianapolis, IN 462601983
(317) 338-5100
Credentials & registration
- NPI registered
- May 2010 — 16 yrs on file
- Profile last updated
- September 7, 2023
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207RC0200X — NUCC code
- State license (1)
- Indiana #01078382A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1144548967. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
867
Distinct HCPCS
10
Medicare allowed
$82,440
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 189 | 106 | $119 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 113 | 60 | $110 | |
94010 |
Test to measure expiratory airflow and volume | 110 | 109 | $25 | |
99291 |
Critical care, first 30-74 minutes | 90 | 47 | $199 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 55 | 53 | $85 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 34 | 34 | $161 | |
31624 |
Irrigation and suction of lung airways to obtain cells using an endoscope | 26 | 25 | $16 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 25 | 18 | $75 | |
94729 |
Test to examine how well the lungs exchange gases | 24 | 24 | $8 | |
31628 |
Biopsy of lobe of lung using an endoscope, 1 lobe | 23 | 22 | $60 |
In context: peer comparison
Among 29 peers in this city , average services per provider: 56. This provider delivers 15× the peer median.Open Payments
Industry payments received
All-time total
$158
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Pulmonx Corporation | 1 | $121.30 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $36.84 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,171
Patients
325
Total drug cost
$551,277
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 234 | 72 | $8,914 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 138 | 29 | $136,367 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 111 | 22 | $68,697 |
| Prednisone | Generic | 105 | 46 | $701 |
| Montelukast Sodium | Generic | 90 | 31 | $1,802 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 86 | 28 | $51,810 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 77 | 19 | $68,013 |
| Azithromycin | Generic | 73 | 31 | $1,971 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 57 | 11 | $46,970 |
| Fluticasone Propionate | Generic | 42 | 12 | $623 |
Hospital affiliations
Frequently asked questions
What is Dr. Mark Mastrodicasa's medical specialty?
Dr. Mark Mastrodicasa practices Critical Care Medicine (Internal Medicine) Physician in Indianapolis, IN.
Where does Dr. Mark Mastrodicasa practice?
Dr. Mark Mastrodicasa practices at 8333 Naab RD Ste 250, Indianapolis, IN 462601983. Office phone: 3173385100.
What is Dr. Mark Mastrodicasa's NPI?
Dr. Mark Mastrodicasa's National Provider Identifier (NPI) is 1144548967, issued by NPPES.
Does Dr. Mark Mastrodicasa accept Medicare assignment?
Yes. Dr. Mark Mastrodicasa accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Mastrodicasa commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Test to measure expiratory airflow and volume (HCPCS 94010). Source: CMS Medicare Physician & Other Practitioners file.